TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | -85.7% | 260 | -86.6% | 0.00% | -83.3% |
Q1 2022 | $28,000 | +21.7% | 1,947 | +15.4% | 0.01% | +20.0% |
Q4 2021 | $23,000 | +283.3% | 1,687 | +347.5% | 0.01% | +400.0% |
Q3 2021 | $6,000 | 0.0% | 377 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $6,000 | -33.3% | 377 | -20.1% | 0.00% | -50.0% |
Q1 2021 | $9,000 | -71.9% | 472 | -73.0% | 0.00% | -71.4% |
Q4 2020 | $32,000 | – | 1,749 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |